Publicaciones (72) Publicaciones de ANTONIO LIRAS MARTÍN

2023

  1. Expresión de factor V de la coagulación en distintas etapas del desarrollo embrionario en ratón

    LXIV Congreso Nacional de la SEHH. XXXVIII Congreso Nacional SETH. 38th World Congress of the International Society of Hematology (ISTH)

  2. La magia de las proteasas: De un factor v procoagulante y anticoagulante a un tratamiento equitativo de su deficiencia hereditaria

    Investigaciones DACIU 2022-2023: Una publicación que refleja los trabajos realizados por los participantes en el programa DACIU en su primera edición (Fundación Avanza), pp. 73-80

  3. The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  4. Therapeutic potential of fetal liver cell transplantation in hemophilia A mice

    Haematologica, Vol. 108, Núm. 6, pp. 1544-1554

  5. Treatment of congenital coagulopathies, from biologic to biotechnological drugs: The relevance of gene editing (CRISPR/Cas)

    Thrombosis Research, Vol. 231, pp. 99-111

2022

  1. Development and Characterization of a Factor V‐Deficient CRISPR Cell Model for the Correction of Mutations

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  2. Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models

    Frontiers in Veterinary Science, Vol. 9

  3. The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. Cell therapy for factor V deficiency: An approach based on human decidua mesenchymal stem cells

    Biomedicine and Pharmacotherapy, Vol. 142

  2. Gene and Cell Therapy in Dental Tissue Regeneration

    Human Tooth and Developmental Dental Defects - Compositional and Genetic Implications

  3. Gene therapy in hemophilia: Recent advances

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

  4. High mutational heterogeneity, and new mutations in the human coagulation factor v gene. Future perspectives for factor v deficiency using recombinant and advanced therapies

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

2019

  1. Dental management of patients with haemophilia in the era of recombinant treatments: Increased efficacy and decreased clinical risk

    BMJ Case Reports, Vol. 12, Núm. 4

2018

  1. Searching for a Cell-Based Therapeutic Tool for Haemophilia A within the Embryonic/Foetal Liver and the Aorta-Gonads-Mesonephros Region

    Thrombosis and Haemostasis, Vol. 118, Núm. 8, pp. 1370-1381

2016

  1. Preliminary study on non-viral transfection of F9 (factor IX) gene by nucleofection in human adipose-derived mesenchymal stem cells

    PeerJ, Vol. 2016, Núm. 4

2015

  1. Biological therapies for inherited diseases: Social and bioethical considerations. Hemophilia as an example

    Expert Opinion on Biological Therapy, Vol. 15, Núm. 5, pp. 713-722

2013

  1. Treatment for hemophilia: Recombinant versus plasma-derived coagulation factors-controversy and debate forever? An ethical medical challenge?

    Expert Review of Hematology, Vol. 6, Núm. 5, pp. 489-492

2012

  1. Advanced therapies for hemophilia: Reality or fantasy?

    Expert Review of Hematology, Vol. 5, Núm. 3, pp. 245-247

  2. Advanced therapies for the treatment of hemophilia: Future perspectives

    Orphanet Journal of Rare Diseases, Vol. 7, Núm. 1

  3. Cartilage restoration in haemophilia: Advanced therapies

    Haemophilia, Vol. 18, Núm. 5, pp. 672-679